Tribune Therapeutics
Stockholm
About Tribune Therapeutics
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: tribunetx.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tribune-therapeutics-22697 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.